Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;140(5):336-341.
doi: 10.1111/ane.13149. Epub 2019 Aug 8.

Multiple sclerosis relapses contribute to long-term disability

Thomas F Scott  1   2 , Daniel Diehl  1 , Wisam Elmalik  1 , Edward J Gettings  3 , Chris Hackett  1 , Carol J Schramke  1   2
Affiliations

Multiple sclerosis relapses contribute to long-term disability

Thomas F Scott et al. Acta Neurol Scand. 2019 Nov.

Abstract

Background: Treatments affect both relapse-related disability and short-term disability change, but measurements of their impact on long-term outcomes remain a challenge.

Objective: To ascertain the contribution of relapse-associated disability to overall disability in relapse-onset multiple sclerosis (RMS) using long-term data collected in our clinic.

Materials and methods: Retrospective study of a cohort of newly diagnosed patients with RMS, (n = 176) was undertaken, measuring all confirmed changes in disability up to 15 years after onset. Worsening was assessed yearly and in 5-year epochs and was attributed to either relapse (RW) or slow progression (PW).

Results: At data lock, 139/176 (81%) of patients were still actively followed, with Expanded Disability Status Scale (EDSS) available for 10 years post-onset in 145/176 (82%) patients and 15 years post-onset EDSS in 83 patients (mean follow-up entire group 12.7 years post-onset). RW accounted for a large amount of worsening seen in the first 15 years of RMS. RW was less frequent over time, but accounted for most EDSS changes in the first decade of MS (167/267, 63% of EDSS changes), and remained important even in years 11-15 (17/50, 34% of EDSS changes). Median change in disability due to RW vs PW was similar over the entire 15 years.

Conclusions: Worsening of treated MS was associated with relapses in many RMS patients throughout the first 15 years after onset, suggesting an opportunity for long-term benefit through relapse reduction.

Keywords: MS; expanded disability status scale; progression; relapse.

PubMed Disclaimer

References

REFERENCES

    1. Scott TF. Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES. Mult Scler J. 2015;21(11):1369-1375.
    1. Kalincik T, Buzzard K, Jokubaitis V, et al. Risk of relapse phenotype recurrence in multiple sclerosis. Mult Scler J. 2014;20:1511-1522.
    1. Scott TF, Kieseier BC, Newsome SD, et al. Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis. Mult Scler J Exp Transl Clin. 2016;2:2055217316676644. https://doi.org/10.1177/2055217316676644.
    1. O'Connor PW, Lublin FD, Wolinsky JS, et al. Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use. J Neurol. 2013;260:2472-2480.
    1. Scalfari A. Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - NO. Mult Scler J. 2015;21(11):1371-1375.

LinkOut - more resources